TABLE 1.
The sensitivity of SBA and HT29 cells to different drugs
| Drug | Cell | IC50 (μmol/L) mean ± SD | P Value |
|---|---|---|---|
| Oxaliplatin | SBA | 0.40 ± 0.08 | .034 |
| HT29 | 0.99 ± 0.16 | ||
| Irinotecan | SBA | 9.86 ± 2.01 | .3 |
| HT29 | 6.60 ± 2.85 | ||
| 5‐FU | SBA | 2.53 ± 2.7 | .61 |
| HT29 | 0.91 ± 0.37 | ||
| Paclitaxel | SBA | 0.055 ± 0.034 | .02 |
| HT29 | 0.0036 ± 0.0014 | ||
| Gemcitabine | SBA | 0.059 ± 0.013 | .0495 |
| HT29 | 0.0047 ± 0.0003 | ||
| Trifluorothymidine | SBA | 65.1 ± 43.6 | .0495 |
| HT29 | 2.1 ± 0.54 |
The selected drugs with P < .05 are shown in bold.
Abbreviations: 5‐FU, 5‐fluorouracil; SBA, small bowel adenocarcinoma; SD, standard deviation